Surgery Partners Plunges 12.43% on Macquarie Downgrade, Fmr LLC Share Sale

On April 14, 2025, Surgery Partners experienced a significant drop of 12.43% in pre-market trading, marking a new one-year low for the company.

Macquarie has revised its expectations for Surgery Partners, lowering its price target for the company's stock. This adjustment reflects a more cautious outlook on the company's future performance, which could be a contributing factor to the recent decline in stock price.

Additionally, Fmr LLC has sold a substantial number of shares in Surgery Partners, which may have influenced investor sentiment and contributed to the stock's downward trend. The sale of such a large number of shares can often signal a lack of confidence in the company's prospects, leading to a decrease in stock value.